Influence of endothelin-1 on hemodynamics during liver transplantation with and without temporary portocaval shunt: Results of a clinical randomized study

Abstract

Aims of this study are to analyze the influence of endothelin-1 (ET-1) on hemodynamic evolution during liver transplantation (LT) and study the role of a temporary portacaval shunt in ET-1 synthesis. Forty LTs in patients with cirrhosis were studied. Two groups were analyzed: the first group had a temporary portacaval shunt during the anhepatic phase, and the second group did not. Portal and systemic ET-1 levels were measured at several times. At the end of the anhepatic phase, systemic (16.1 ± 6.5 pg/mL) and portal (19.2 ± 7 pg/mL) ET-1 levels increased, whereas they decreased after reperfusion (systemic, 11.8 ± 7.1 pg/mL; portal, 13.2 ± 6.8 pg/mL). Portal flow at the beginning of LT correlated with systemic ET-1 levels (R2 = 0.3; P = .004). A temporary portacaval shunt reduced portal pressure during the an hepatic phase, but did not modify ET-1 levels. Patients with reperfusion syndrome had greater systemic ET-1 levels in the anhepatic phase (19.1 ± 6.9 v 15.1 ± 6.1 pg/mL; P = .07). Although there is a relationship between ET-1 levels and portal flow and reperfusion syndrome, no clear clinical effect on hemodynamics could be shown. Creation of a portacaval shunt made no change in ET-1 levels.